The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Economic Impact of Antimicrobial Resistance
Open accessAbstract
One reason antimicrobial-drug resistance is of concern is its economic impact on physicians, patients, health-care administrators, pharmaceutical producers, and the public. Measurement of cost and economic impact of programs to minimize antimicrobial-drug resistance is imprecise and incomplete. Studies to describe and evaluate the problem will have to employ new methods and be of large scale to produce information that is broadly applicable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
Cohen, M. L. (1992) · Science · doi:10.1126/science.257.5073.1050 · Cited by 1,304
Austin, D. J., Kristinsson, K. G., & Anderson, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1152 · Cited by 784
Shlaes, D. M., Gerding, D. N., John, Jr., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513766 · Cited by 780
Self-citationMortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.2.223 · Cited by 589
The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals
Rubin, R. J., Harrington, C. A., Poon, A., Dietrich, K., Greene, J. A., & Moiduddin, A. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0501.990102 · Cited by 445
Gonzalez, C., Rubio, M., Romero-Vivas, J., Gonzalez, M., & Picazo, J. J. (1999) · Clinical Infectious Diseases · doi:10.1086/313440 · Cited by 407
White, A. C., Atmar, R. L., Wilson, J., Cate, T. R., Stager, C. E., & Greenberg, S. B. (1997) · Clinical Infectious Diseases · doi:10.1086/514545 · Cited by 371
Health and Economic Outcomes of Antibiotic Resistance in Pseudomonas aeruginosa
Carmeli, Y., Troillet, N., Karchmer, A. W., & Samore, M. H. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1127 · Cited by 363
Abramson, M. A., & Sexton, D. J. (1999) · Infection Control & Hospital Epidemiology · doi:10.1086/501641 · Cited by 314
Pathogenic Significance of Methicillin Resistance for Patients with Staphylococcus aureus Bacteremia
Soriano, A., Martinez, J. A., Mensa, J., Marco, F., Almela, M., Moreno-Martinez, A., Sanchez, F., Munoz, I., Jimenez de Anta, M. T., & Soriano, E. (2000) · Clinical Infectious Diseases · doi:10.1086/313650 · Cited by 256
A review of the role of antibiotic policies in the control of antibiotic resistance
Gould, I. M. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.459 · Cited by 241
Antibiotic Resistance—Squeezing the Balloon?
Burke, J. P. (1998) · JAMA · doi:10.1001/jama.280.14.1270 · Cited by 237
The Economic Impact of Methicillin-Resistant Staphylococcus aureus in Canadian Hospitals
Kim, T., Oh, P. I., & Simor, A. E. (2001) · Infection Control & Hospital Epidemiology · doi:10.1086/501871 · Cited by 213
The Quality of Reporting in Published Cost-Utility Analyses, 1976–1997
Neumann, P. J., Stone, P. W., Chapman, R. H., Sandberg, E. A., & Bell, C. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-12-200006200-00007 · Cited by 208
Shlaes, D. M., Gerding, D. N., John, J. F., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Infection Control & Hospital Epidemiology · doi:10.1086/647610 · Cited by 206
Self-citationBhavnani, S. M., Drake, J. A., Forrest, A., Deinhart, J. A., Jones, R. N., Biedenbach, D. J., & Ballow, C. H. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00136-4 · Cited by 179
Superbugs: Should antimicrobial resistance be included as a cost in economic evaluation?
Coast, J., Smith, R., & Millar, M. R. (1996) · Health Economics · Cited by 138
Bug/Drug Resistance: Sometimes Less is More
Phelps, C. E. (1989) · Medical Care · doi:10.1097/00005650-198902000-00009 · Cited by 131
Bug/drug resistance. Sometimes less is more.
Phelps, C. E. (1989) · PubMed · Cited by 120
Lawton, R. M., Fridkin, S. K., Gaynes, R. P., et al. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501754 · Cited by 112
Association Between Resistance to Vancomycin and Death in Cases of Enterococcus faecium Bacteremia
Garbutt, J. M., Ventrapragada, M., Littenberg, B., & Mundy, L. M. (2000) · Clinical Infectious Diseases · doi:10.1086/313694 · Cited by 112
Epidemiology of extended spectrum β-lactamases
Philippon, A., Redjeb, S. B., Hassen, A. B., & Fournier, G. (1989) · Infection · doi:10.1007/bf01650727 · Cited by 111
Rennie, D., & Luft, H. S. (2000) · JAMA · doi:10.1001/jama.283.16.2158 · Cited by 107
Ms, I., & Bruining, H. A. (2002) · The European Journal of Surgery · doi:10.1080/110241598750004210 · Cited by 107
Lai, K. K., Kelley, A. L., Melvin, Z. S., Belliveau, P., & Fontecchio, S. A. (1998) · Infection Control and Hospital Epidemiology · doi:10.1086/647892 · Cited by 103
Report of the ASM task force on antibiotic resistance.
(1995) · PubMed · Cited by 95
An economic perspective on policy to reduce antimicrobial resistance
Coast, J., Smith, R., & Millar, M. R. (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(97)00132-9 · Cited by 86
Sigurdur Einarsson, M. K. (1998) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365549850160882 · Cited by 86
A Novel Antimicrobial Agent Joins the Battle against Resistant Bacteria
Moellering, R. C. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-2-199901190-00012 · Cited by 85
Economic Evaluations of Antibiotic Use and Resistance-A Perspective: Report of Task Force 6
Liss, R. H., & Batchelor, F. R. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_3.s297 · Cited by 71
Vanhems, P., Lepape, A., Savey, A., Jambou, P., & Fabry, J. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.2000.0752 · Cited by 53
Control Group Selection Is an Important but Neglected Issue in Studies of Antibiotic Resistance
Harris, A. D. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-11-200006060-00024 · Cited by 44
Control Group Selection Is an Important but Neglected Issue in Studies of Antibiotic Resistance
Harris, A. D., Samore, M. H., & Carmeli, Y. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00018 · Cited by 29
Nathwani, D., & Malek, M. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00102-8 · Cited by 13
Cited by
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Self-citationMechanisms of Antimicrobial Resistance in Bacteria
Tenover, F. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.011 · Cited by 1,682
The Impact of Antimicrobial Resistance on Health and Economic Outcomes
Eliopoulos, G. M., Cosgrove, S. E., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/375081 · Cited by 637
Mechanisms of antimicrobial resistance in bacteria
Tenover, F. C. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.219 · Cited by 637
Antibiotic prescribing in hospitals: a social and behavioural scientific approach
Hulscher, M. E., Grol, R. P., & van der Meer, J. W. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70027-x · Cited by 362
Metadata
- Authors
- McGowan, J. E.
- Venue
- Emerging Infectious Diseases
- Published
- 2001-03
- Volume
- 7
- Issue
- 2
- Pages
- 286-292
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2033853571
- Cited by
- 271
- References
- 35
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.